| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/25/1993 | US5214052 Method for dissolving arginineamides and pharmaceutical compositions containing them |
| 05/25/1993 | US5214033 Factor VIII coagulant polypeptides |
| 05/25/1993 | US5214032 Hair growth stimulants |
| 05/25/1993 | US5214030 Urogenital disorders |
| 05/25/1993 | US5214029 Inhibition of malignant cells having GM1 ganglo-side sites by administration of cholera toxin |
| 05/25/1993 | US5214028 Skin whitening |
| 05/25/1993 | US5213978 Protease from micrococcus sedentarius for degrading protein of human callus or corn tissue |
| 05/25/1993 | US5213977 Serine protease from cytotoxic killer cells |
| 05/25/1993 | US5213970 Human monocyte toxin released from human cells |
| 05/25/1993 | US5213810 Stable compositions for parenteral administration and method of making same |
| 05/25/1993 | US5213804 Localized delivery of antibiotic to tumor via bloodstream, encapsulation in liposome |
| 05/25/1993 | US5213797 Excellent activity against grampositive bacteria; increased feed-utilization efficiency and improved weight gains in animals |
| 05/25/1993 | CA1318463C Polypeptide compounds having growth hormone releasing activity |
| 05/25/1993 | CA1318461C Tripeptide derivatives |
| 05/25/1993 | CA1318457C Partially retro-inverted tuftsin analogues, method for the preparation thereof and pharmaceutical compositions containing them |
| 05/25/1993 | CA1318456C Peptides |
| 05/25/1993 | CA1318249C Sustained release compositions for parenteral administration and their use |
| 05/25/1993 | CA1318169C Food compositions with superior blood cholesterol lowering properties |
| 05/20/1993 | WO1993010147A1 Novel amylin antagonist peptides and uses therefor |
| 05/20/1993 | CA2100743A1 Amylin antagonist peptides and uses therefor |
| 05/19/1993 | EP0542679A1 Novel hybrid transforming growth factors |
| 05/19/1993 | EP0542629A1 Recombinant gastric lipase from rabbit and pharmaceutical compositions |
| 05/19/1993 | EP0542549A1 Use of cosmetic composition |
| 05/19/1993 | EP0542525A2 Antithrombotic agents |
| 05/19/1993 | EP0542424A1 Oxytocin recepto and DNA coding for the same |
| 05/19/1993 | EP0542314A1 Formation of protein microparticles by antisolvent precipitation |
| 05/19/1993 | EP0541952A1 Mutant human prourokinase |
| 05/19/1993 | EP0541920A1 Interleukin-1 inhibitors |
| 05/19/1993 | EP0541822A1 Novel calcitonin, and production and use thereof |
| 05/19/1993 | EP0541753A1 NOVEL HYBRID, SOLUBLE AND UNCLEAVED gp160 VARIANT. |
| 05/19/1993 | EP0541726A1 Growth factor compositions, preparation and use |
| 05/19/1993 | EP0541721A1 Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system |
| 05/19/1993 | EP0541716A1 Novel methods and compositions for treatment of angiogenic diseases |
| 05/19/1993 | EP0541701A1 INTERLEUKIN-4 AND INTERLEUKIN-1$g(b) SYNERGISTICALLY INDUCE VCAM-1 |
| 05/19/1993 | EP0541694A1 Method for treating immune system dysfunctions |
| 05/19/1993 | EP0541692A1 Herpes simplex virus vp16 vaccines |
| 05/19/1993 | EP0541691A1 Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers |
| 05/19/1993 | EP0541686A1 Tachykinin agonists for treatment of alzheimer's disease |
| 05/19/1993 | EP0541663A1 Peptides and pharmaceutical compositions having glycoprotein hormone agonistic or antagonistic activity |
| 05/19/1993 | EP0541654A1 Bombesin antagonists |
| 05/19/1993 | EP0541629A1 CLONING AND EXPRESSION OF A RHOPTRY ASSOCIATED PROTEIN OF $i(P.FALCIPARUM) |
| 05/19/1993 | EP0179075B1 Virus risk-reduced hemoglobin and method for making same |
| 05/19/1993 | DE4137333A1 Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung Therapeutic agents which are antagonists or partial agonists of human interleukin 4 are or contain hIL-4 mutant proteins as well as for their preparation vefahren |
| 05/18/1993 | US5212295 Monomers for preparation of oligonucleotides having chiral phosphorus linkages |
| 05/18/1993 | US5212290 Monoclonal and polyclonal antibodies |
| 05/18/1993 | US5212286 Atrial natriuretic/vasodilator peptide compounds |
| 05/18/1993 | US5212165 Enzyme inhibitor |
| 05/18/1993 | US5212160 Autoimmune disease, aging or bronchopulmonary disease |
| 05/18/1993 | US5212159 Anticataract composition |
| 05/18/1993 | US5212158 Nootropic agents |
| 05/18/1993 | US5212157 Tetrapeptides as inhibitors of HIV |
| 05/18/1993 | US5212156 Srif-related peptides and uses thereof |
| 05/18/1993 | US5212155 Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof |
| 05/18/1993 | US5212154 Preparation for treating complications in diabetes |
| 05/18/1993 | US5212091 Method of producing tissue factor pathway inhibitor |
| 05/18/1993 | US5212085 Monoclonal antibodies |
| 05/18/1993 | US5212074 Genetic material encoding new insulin-like growth factor binding protein igfbp-6 |
| 05/18/1993 | US5212072 Genetic engineering and DNA sequences |
| 05/18/1993 | US5212071 Nucleic acids encoding a human C3b/C4b receptor (CR1) |
| 05/18/1993 | US5211952 Contraceptive methods and formulations for use therein |
| 05/18/1993 | US5211950 Stabilized calcitonin pharmaceutical composition |
| 05/18/1993 | US5211947 Method for lowering blood cholesterol levels with granulocyte-macrophage colony stimulating factor |
| 05/18/1993 | US5211945 Compositions and methods for modulating the effect of tnf and il-1 |
| 05/18/1993 | US5211657 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
| 05/18/1993 | CA1317900C Antibiotic a 40926 complex and its pure factors pa, pb, a, b, and b |
| 05/18/1993 | CA1317899C Stabilization of antibodies |
| 05/18/1993 | CA1317880C Method of reducing tissue damage at an inflammatory site using a monoclonal antibody |
| 05/18/1993 | CA1317878C Method and therapeutic compositions for the treatment of bleeding disorders |
| 05/16/1993 | CA2082693A1 Use of cosmetic compositon |
| 05/13/1993 | WO1993009236A1 Myogenic vector systems |
| 05/13/1993 | WO1993009234A2 Suppressor and progenitor cells |
| 05/13/1993 | WO1993009233A2 Recombinant amyloid precursor protein inhibitor domain and treatment of various disease states |
| 05/13/1993 | WO1993009232A1 NOVEL THROMBIN INHIBITOR PROTEIN FROM $i(REDUVII) |
| 05/13/1993 | WO1993009231A1 Novel thrombin-inhibiting protein from ticks |
| 05/13/1993 | WO1993009230A1 Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids |
| 05/13/1993 | WO1993009229A1 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 05/13/1993 | WO1993009228A1 TGF-β TYPE RECEPTOR cDNAS AND USES THEREFOR |
| 05/13/1993 | WO1993009227A1 Human neuropeptide y-y1 receptor |
| 05/13/1993 | WO1993009226A1 Novel endopeptidase and peptide substrate cleaving and inactivating activity thereof |
| 05/13/1993 | WO1993009222A2 Transfection of vertebrate cells e.g. by homologous recombination |
| 05/13/1993 | WO1993009143A1 Production and use of multimeric hemoglobins |
| 05/13/1993 | WO1993009141A1 Antigen associated with type i diabetes mellitus |
| 05/13/1993 | WO1993009137A1 Inhibitors of collagen-induced platelet aggregation |
| 05/13/1993 | WO1993009136A1 Phosphonopeptides with collagenase inhibiting activity |
| 05/13/1993 | WO1993009135A1 Peptides inhibiting il-1 beta release |
| 05/13/1993 | WO1993009134A1 Phosphonamidate ester-containing pseudopeptides |
| 05/13/1993 | WO1993009130A1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 05/13/1993 | WO1993009101A1 Mercapto-amide derivatives as inhibitors of the neutral endopeptidase |
| 05/13/1993 | WO1993008866A1 Perforated balloon catheter delivery of somatostatin analogues for reducing cell proliferation |
| 05/13/1993 | WO1993008843A1 Trapped cells and use thereof as a drug |
| 05/13/1993 | WO1993008842A1 Hemoglobins as drug delivery agents |
| 05/13/1993 | WO1993008837A1 Stabilised antibodies |
| 05/13/1993 | WO1993008835A1 Cd8+ cell antiviral factor |
| 05/13/1993 | WO1993008832A1 Stabilization of human interferon |
| 05/13/1993 | WO1993008831A1 Expression of recombinant hemoglobin and hemoglobin variants in yeast |
| 05/13/1993 | WO1993008830A1 Compounds of bioavailable iron with acylated ovotransferrin or with acylated hydrolysis derivatives thereof |
| 05/13/1993 | WO1993008829A1 Compositions that mediate killing of hiv-infected cells |
| 05/13/1993 | WO1993008828A1 Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration |
| 05/13/1993 | WO1993008827A1 Natural killer cell enhancing factor |
| 05/13/1993 | WO1993008826A1 Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs |